Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Sep 6;8(9):378.
doi: 10.3390/antiox8090378.

Analysis of Oxidative Stress-Related Markers in Crohn's Disease Patients at Surgery and Correlations with Clinical Findings

Cristina Luceri  1 , Elisabetta Bigagli  2 , Sara Agostiniani  3 , Francesco Giudici  4 , Daniela Zambonin  4 , Stefano Scaringi  5 , Ferdinando Ficari  4 , Maura Lodovici  3 , Cecilia Malentacchi  6
Affiliations

Analysis of Oxidative Stress-Related Markers in Crohn's Disease Patients at Surgery and Correlations with Clinical Findings

Cristina Luceri et al. Antioxidants (Basel). .

Abstract

Crohn' disease (CD) patients are at high risk of postoperative recurrence and new tools for the assessment of disease activity are needed to prevent long-term complications. In these patients, the over-production of ROS generated by inflamed bowel tissue and inflammatory cells activates a pathogenic cascade that further exacerbates inflammation and leads to increased oxidative damage to DNA, proteins, and lipids. We measured the products of protein/lipid oxidation and the total antioxidant capacity (ferric reducing ability of plasma, FRAP) in the serum of CD patients with severe disease activity requiring surgery with the aim to characterize their redox status and identify associations between oxidative stress-related markers and their clinical characteristics. At the systemic level, CD was associated with increased levels of protein and lipid oxidation products when compared to healthy volunteers, even though the FRAP values were similar. Advanced oxidation protein product (AOPP) levels showed the highest difference between patients and the controls (11.25, 5.02-15.15, vs. 1.36, 0.75-2.70, median, interquartile range; p < 0.0001) and the analysis of receiver operating characteristic (ROC) curves, indicated for AOPP, the best area under the curve (AUC) value for CD prediction. Advanced glycated end-products (AGEs) were also significantly higher in CD patients (p < 0.01), which is of interest since AOPP and AGEs are both able to activate the membrane receptor for advanced glycation end products (RAGE) involved in inflammatory diseases. Thiobarbituric acid reactive substance (TBARS) levels were significantly higher in CD patients with ileal localization and aggressive disease behavior, in smokers, and in patients suffering from allergies. In conclusion, our data indicate that circulating oxidative stress biomarkers may be attractive candidates as disease predictors as well as for clinical or therapeutic monitoring of CD. Our results also suggest that AOPP/AGEs and RAGE signaling may represent a pathogenic factor and a potential therapeutic target in CD.

Keywords: Crohn’ disease; biomarkers; oxidative stress.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflicts of interest.

Figures

Figure 1
Figure 1
(A) Scatter dot plot of the advanced oxidation protein products (AOPP) levels in the serum of Crohn’ patients and healthy volunteers. **** p < 0.0001 by Mann–Whitney test. (B) ROC curve for AOPP.
Figure 2
Figure 2
Correlation between AOPP and TBARS levels in the serum of Crohn’s patients.
See this image and copyright information in PMC

References

    1. Molodecky N.A., Soon I.N.G.S., Rabi D.M., Ghali W.A., Ferris M., Chernoff G., Benchimol E.I., Panaccione R., Ghosh S., Barkema H.W. Increasing incidence and prevalence of the Inflammatory Bowel Diseases. YGAST. 2012;142:46–54. - PubMed
    1. Ng S.C., Shi H.Y., Hamidi N., Underwood F.E., Tang W., Benchimol E.I., Panaccione R., Ghosh S., Wu J.C.Y., Chan F.K.L., et al. Articles worldwide incidence and prevalence of Inflammatory Bowel Disease in the 21st century: A systematic review of population-based studies. Lancet. 2017;390:2769–2778. doi: 10.1016/S0140-6736(17)32448-0. - DOI - PubMed
    1. Torres J., Mehandru S., Colombel J.F., Peyrin-Biroulet L. Crohn’s disease. Lancet. 2017;389:1741–1755. doi: 10.1016/S0140-6736(16)31711-1. - DOI - PubMed
    1. Pereira C., Gracio D., Teixeira J.P., Magro F. Oxidative stress and DNA damage: Implications in Inflammatory Bowel Disease. Inflamm. Bowel Dis. 2015;21:16–19. doi: 10.1097/MIB.0000000000000506. - DOI - PubMed
    1. Patlevic P., Vascova J., Svork P., Jr., Vasko L., Svork P. Reactive oxygen species and antioxidant defense in human gastrointestinal diseases. Integr. Med. Res. 2016;5:250–258. doi: 10.1016/j.imr.2016.07.004. - DOI - PMC - PubMed

LinkOut - more resources